Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07084844 · ClinicalTrials.gov registry record

Patient Reported Outcomes With WaveLight Plus LASIK

A clinical trial of Myopia and Astigmatism, sponsored by Mann Eye Institute.

Recruiting
Registry status
52
Enrollment target
1
Study location

NCT07084844 is a study of Myopia and Astigmatism that is actively recruiting participants, run by Mann Eye Institute. The registered enrollment target is 52 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07084844, a study of Myopia and Astigmatism, is actively recruiting participants, sponsored by Mann Eye Institute.

RECRUITING
Registry status
52 participants
Enrollment target
1
Study location

Study Summary

This study is a single-site, single-arm, prospective, observational study of subject satisfaction, quality of vision, and quality of life after bilateral LASIK surgery. Subjects will be assessed up to 3 months post-operatively. Clinical evaluations will include refractive outcomes, visual acuity, and administration of the adapted PROWL and the Quality-of-Life Impact of Refractive Correction (QIRC) Questionnaire.

Conditions Studied

Interventions

  • DEVICE WaveLigh Plus LASIK

Study Locations (1)

Texas

  • Mann Eye Institute - Houston

Trial Details

FieldValue
Enrollment Target 52 participants
Start Date 2025-09-05
Est. Completion 2026-09-01

Sponsor

Mann Eye Institute

6 total trials

What the Registry Record Tells You About NCT07084844

The ClinicalTrials.gov registry entry for NCT07084844 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (81% lower). The listed sponsor is Mann Eye Institute, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Myopia appearing as the primary indexed condition, and to 1 intervention - of which WaveLigh Plus LASIK is the first listed.

NCT07084844 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT07084844 about?

NCT07084844 is a clinical study titled "Patient Reported Outcomes With WaveLight Plus LASIK". This study is a single-site, single-arm, prospective, observational study of subject satisfaction, quality of vision, and quality of life after bilateral LASIK surgery. Subjects will be assessed up to 3 months post-operatively. Clinical evaluations will include refractive outcomes, visual acuity, an...

What is the current status of trial NCT07084844?

This trial is currently recruiting. The enrollment target is 52 participants. The study started on 2025-09-05. Estimated completion is 2026-09-01.

What conditions does trial NCT07084844 study?

This clinical trial studies the following conditions: Myopia, Astigmatism.

What interventions are being tested in trial NCT07084844?

The interventions under investigation include: WaveLigh Plus LASIK (DEVICE).

Who is sponsoring clinical trial NCT07084844?

This trial is sponsored by Mann Eye Institute, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07084844 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.